


Healthcare News Roundup: Generic
HSMN NewsFeed - 23 May 2008
Akorn-Strides, LLC Announces FDA Approval for Rifampin for Injection USP, 600 mg/Vial
Akorn-Strides, LLC Announces FDA Approval for Rifampin for Injection USP, 600 mg/Vial
HSMN NewsFeed - 15 May 2008
KV Pharmaceutical Company Announces Approval for the 50 mg Strength of Generic Version of Toprol-XL(R)
KV Pharmaceutical Company Announces Approval for the 50 mg Strength of Generic Version of Toprol-XL(R)
HSMN NewsFeed - 15 May 2008
Valeant Pharmaceuticals Announces FDA Has Initiated Reconsideration of Generic Efudex(R) Approval
Valeant Pharmaceuticals Announces FDA Has Initiated Reconsideration of Generic Efudex(R) Approval
HSMN NewsFeed - 14 May 2008
Simcere Pharmaceutical Group Announces SFDA Approval of First-to-Market Generic Biapenem Injection Anxin
Simcere Pharmaceutical Group Announces SFDA Approval of First-to-Market Generic Biapenem Injection Anxin
HSMN NewsFeed - 9 May 2008
Spectrum Pharmaceuticals Announces Sale of Injectable Generic Drugs to Sagent Pharmaceuticals, Inc.
Spectrum Pharmaceuticals Announces Sale of Injectable Generic Drugs to Sagent Pharmaceuticals, Inc.
HSMN NewsFeed - 30 Apr 2008
U.S. Patent and Trademark Office to Confirm Patentability of Lipitor Basic Patent
U.S. Patent and Trademark Office to Confirm Patentability of Lipitor Basic Patent
HSMN NewsFeed - 24 Apr 2008
Lannett Company Receives Approval for Dipyridamole Tablets USP, 25 mg, 50 mg, and 75 mg
Lannett Company Receives Approval for Dipyridamole Tablets USP, 25 mg, 50 mg, and 75 mg
HSMN NewsFeed - 21 Apr 2008
Mylan Announces Final FDA Approval for Felodipine Extended-Release Tablets, USP
Mylan Announces Final FDA Approval for Felodipine Extended-Release Tablets, USP
HSMN NewsFeed - 21 Apr 2008
APP Pharmaceuticals Receives FDA Approval for Colistimethate For Injection, USP
APP Pharmaceuticals Receives FDA Approval for Colistimethate For Injection, USP
HSMN NewsFeed - 18 Apr 2008
Caraco Pharmaceutical Laboratories Ltd. Wins Summary Judgment on Generic Ultracet(R)
Caraco Pharmaceutical Laboratories Ltd. Wins Summary Judgment on Generic Ultracet(R)
HSMN NewsFeed - 18 Apr 2008
Akorn, Inc. Announces FDA Approval of Diclofenac Sodium Ophthalmic Solution 0.1%
Akorn, Inc. Announces FDA Approval of Diclofenac Sodium Ophthalmic Solution 0.1%
HSMN NewsFeed - 16 Apr 2008
Akorn, Inc. Announces FDA Approval of Ofloxacin Ophthalmic Solution USP, 0.3%
Akorn, Inc. Announces FDA Approval of Ofloxacin Ophthalmic Solution USP, 0.3%
HSMN NewsFeed - 15 Apr 2008
Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation
Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation
